华兰生物(002007)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002007 华兰生物

已收盘 07-31 15:00:00

{"stockData":{"symbol":"002007","market":"SZ","secType":"STK","nameCN":"华兰生物","latestPrice":13.44,"timestamp":1785481425000,"preClose":13.48,"halted":0,"volume":19009631,"delay":0,"changeRate":-0.003,"floatShares":1574000000,"shares":1826000000,"eps":0.4698,"marketStatus":"已收盘","change":-0.04,"latestTime":"07-31 15:00:00","open":13.43,"high":13.73,"low":13.4,"amount":258000000,"amplitude":0.0245,"askPrice":13.44,"askSize":2288,"bidPrice":13.43,"bidSize":128,"shortable":0,"etf":0,"ttmEps":0.4698,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1785720600000},"marketStatusCode":5,"adr":0,"adjPreClose":13.48,"symbolType":"stock","openAndCloseTimeList":[[1785461400000,1785468600000],[1785474000000,1785481200000]],"highLimit":14.83,"lowLimit":12.13,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1825690986,"isCdr":false,"pbRate":2.1,"roa":"--","peRate":28.607918,"roe":"1.98%","epsLYR":0.5151,"committee":-0.406502,"marketValue":24537000000,"turnoverRate":0.0121,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-08-03。","floatMarketCap":21148000000},"requestUrl":"/m/hq/s/002007/","defaultTab":"news","newsList":[{"id":"2652898602","title":"华兰生物（002007）披露高级管理人员辞职公告，7月17日股价下跌3.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652898602","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652898602?lang=zh_cn&edition=full","pubTime":"2026-07-17 22:14","pubTimestamp":1784297657,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，华兰生物报收于13.18元，较前一交易日下跌3.51%，最新总市值为240.63亿元。近日，华兰生物工程股份有限公司披露《关于高级管理人员辞职的公告》。公告显示，公司董事会收到高级管理人员陈正跃先生提交的书面辞职报告。其辞职报告自送达董事会之日起生效，不影响公司相关工作正常进行。截至公告日，陈正跃先生持有公司股票34,000股，将继续遵守有关离任高管减持股份的法律法规。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700044686.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0188","BK0197","002007","BK0077","BK0239","BK0046","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648506024","title":"华兰生物最新公告：参股公司撤回利妥昔单抗注射液注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2648506024","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648506024?lang=zh_cn&edition=full","pubTime":"2026-07-02 18:00","pubTimestamp":1782986454,"startTime":"0","endTime":"0","summary":"华兰生物(002007.SZ)公告称，公司参股公司华兰安康收到国家药监局签发的《药品注册申请终止通知书》，同意利妥昔单抗注射液(HL03)注册申请的撤回。该药品因需进一步完善申报资料，华兰安康决定撤回申请，后续将补充完善相关研究工作后重启注册程序。本次撤回不会对公司当期及未来经营、业绩造成重大不利影响。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200031222.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0185","BK0077","BK0188","BK0197","002007","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648251715","title":"股市必读：华兰生物（002007）7月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2648251715","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648251715?lang=zh_cn&edition=full","pubTime":"2026-07-02 04:00","pubTimestamp":1782936040,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，华兰生物报收于12.6元，上涨3.36%，换手率1.05%，成交量16.52万手，成交额2.06亿元。公司聚焦生物制品主业，目前暂无投资其他非相关领域计划。交易信息汇总资金流向7月1日主力资金净流出435.77万元，占总成交额0.0%；游资资金净流出151.88万元，占总成交额0.0%；散户资金净流入587.66万元，占总成交额0.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200001892.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0028","BK0046","BK0239","BK0077","002007","BK0197","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648112625","title":"华兰生物：公司聚焦生物制品主业，目前暂无投资其他非相关领域计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2648112625","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648112625?lang=zh_cn&edition=full","pubTime":"2026-07-01 17:57","pubTimestamp":1782899828,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)07月01日在投资者关系平台上答复投资者关心的问题。投资者提问：汤臣倍健都进军芯片行业了，华兰帐上现金那么多，医药行业未来几年都看不到前景，不如也考虑一下投资点大模型？ 你看九安医疗把当初口罩赚的钱投了kimi和deepseek，今年涨势很好。华兰生物回复：您好！公司聚焦生物制品主业，目前暂无投资其他非相关领域计划。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100034928.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002007","BK0077","BK0239","BK0188","BK0185","BK0046","BK0028","BK0197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641148745","title":"华兰生物：公司董事长等增持股票149.57万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641148745","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641148745?lang=zh_cn&edition=full","pubTime":"2026-06-05 20:52","pubTimestamp":1780663948,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物06月04日在投资者关系平台上答复投资者关心的问题。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500038818.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","BK0028","BK0239","BK0046","BK0197","002007","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641111770","title":"华兰生物最新公告：控股子公司获新型佐剂流感病毒裂解疫苗临床试验批准国内尚无同类佐剂流感疫苗获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2641111770","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641111770?lang=zh_cn&edition=full","pubTime":"2026-06-05 18:00","pubTimestamp":1780653632,"startTime":"0","endTime":"0","summary":"华兰生物(002007.SZ)公告称，公司控股子公司华兰疫苗收到国家药品监督管理局下发的《药物临床试验批准通知书》，同意开展新型佐剂流感病毒裂解疫苗的临床试验。该疫苗采用以角鲨烯为主要成分的佐剂系统，接种本疫苗后，可刺激机体产生抗流感病毒的免疫力，用于预防疫苗相关型别的流感病毒引起的流行性感冒，尤其是增强老年人等免疫力较弱人群对流感病毒的免疫反应水平。目前国内尚无同类佐剂流感疫苗获批上市，此次获批有助于丰富产品管线，但后续临床试验及上市存在不确定性。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500031282.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0028","159646","BK0077","BK0185","002007","BK0197","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640583150","title":"华兰生物：深耕主业，夯实公司价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2640583150","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640583150?lang=zh_cn&edition=full","pubTime":"2026-06-04 20:48","pubTimestamp":1780577319,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物06月03日在投资者关系平台上答复投资者关心的问题。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400039309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0046","BK0239","BK0188","BK0077","002007","BK0028","BK0197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640970933","title":"华兰生物：公司目前无私有化计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2640970933","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640970933?lang=zh_cn&edition=full","pubTime":"2026-06-03 17:15","pubTimestamp":1780478123,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)06月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵司有没有可能私有化？考虑到整个血制品板块估值低迷，面临流动性枯竭和融资功能丧失，另外从贵司的派现融资比来看，市值远低于内在价值。综上所述，私有化是一个比较好的选择。华兰生物回复：您好！公司目前无私有化计划。公司始终聚焦主业，稳健经营。后续将持续通过优化治理、提升信披质量、强化股东回报等措施加强市值管理，努力推动价值合理回归。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300034800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0239","BK0188","BK0028","002007","BK0046","BK0077","BK0197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638988590","title":"华兰生物：2025年营收增长主要由于人血白蛋白、流感疫苗及其他血液制品","url":"https://stock-news.laohu8.com/highlight/detail?id=2638988590","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638988590?lang=zh_cn&edition=full","pubTime":"2026-05-26 17:21","pubTimestamp":1779787267,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物05月26日在投资者关系平台上答复投资者关心的问题。请问管理层能否集中说明：2025年营收增长的主要驱动力来自哪些产品？＂华兰生物回复：2025年营收增长主要由于人血白蛋白、流感疫苗及其他血液制品，但由于2022-2024年全国采浆量增长较快，需求端受限于医疗政策DRG/DIP改革、医保控费等因素的影响，行业整体库存增加，市场竞争加剧，血液制品价格下降，整体净利润率较上年同期有一定下滑。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600029076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638959083","title":"华兰生物：2026年1季度经营活动产生的现金流量净额为-6,389,579.43元","url":"https://stock-news.laohu8.com/highlight/detail?id=2638959083","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638959083?lang=zh_cn&edition=full","pubTime":"2026-05-26 17:18","pubTimestamp":1779787089,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物05月26日在投资者关系平台上答复投资者关心的问题。2026年一季度经营性现金流转为净流出。＂华兰生物回复：2025年，公司筹资活动产生的现金流量净额本期发生额较上期发生额下降155.89%，主要系本期偿还借款及分配股利支付的现金增加所致；2026年1季度经营活动产生的现金流量净额为-6,389,579.43元，较上年同期有所减少，主要原因系本期购买商品支付的现金增加所致。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600028960.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0046","BK0197","BK0077","BK0239","002007","BK0185","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638551122","title":"股市必读：华兰生物（002007）5月25日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2638551122","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638551122?lang=zh_cn&edition=full","pubTime":"2026-05-26 01:21","pubTimestamp":1779729670,"startTime":"0","endTime":"0","summary":"截至2026年5月25日收盘，华兰生物报收于13.72元，下跌1.01%，换手率0.48%，成交量7.63万手，成交额1.05亿元。董秘最新回复投资者： 现在公司血制品院外市场占比多少？","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600001137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002007","BK0185","BK0197","BK0028","BK0077","BK0188","BK0239","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638534222","title":"华兰生物：公司将持续稳健经营，以扎实的业绩支撑公司长期价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2638534222","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638534222?lang=zh_cn&edition=full","pubTime":"2026-05-25 18:21","pubTimestamp":1779704477,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)05月25日在投资者关系平台上答复投资者关心的问题。投资者提问：公司手握大量资金不投资科技行业也不增持公司股票增加机构投资者信心，只做分红最大利好限售股东，默守成规血制品夕阳产业，造成公司股价连续下跌再创新低，管理团队过于保守，缺乏活力，能否吸取投资者建议华兰生物回复：您好！股价受市场环境、经营业绩及行业发展前景等多重因素综合影响。公司将持续稳健经营，以扎实的业绩支撑公司长期价值。感谢您的关注和对公司的建议！以上内容为证券之星据公开信息整理，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500026327.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0185","BK0046","BK0197","BK0239","002007","BK0077","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638273534","title":"华兰生物：现金分红是公司回馈股东的重要方式","url":"https://stock-news.laohu8.com/highlight/detail?id=2638273534","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638273534?lang=zh_cn&edition=full","pubTime":"2026-05-25 18:21","pubTimestamp":1779704476,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)05月25日在投资者关系平台上答复投资者关心的问题。投资者提问：公司股价持续下跌7年，公司从一流企业发展成为四五流企业，与公司管理是分不开的，为了大股东利益大比例分红，为什么不用分红的钱拓展发展新空间或回购增加投资者信心？华兰生物回复：您好！股价受市场环境、经营业绩及行业发展前景等多重因素综合影响。现金分红是公司回馈股东的重要方式，亦是落实监管导向、保障股东合理回报的重要举措。公司将持续稳健经营，以扎实的业绩支撑公司长期价值。感谢您的关注和对公司的建议！以上内容为证券之星据公开信息整理，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500026326.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","BK0028","BK0239","BK0046","BK0197","002007","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638534274","title":"华兰生物：公司将院外市场及下沉市场作为核心战略拓展方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2638534274","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638534274?lang=zh_cn&edition=full","pubTime":"2026-05-25 18:21","pubTimestamp":1779704474,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)05月25日在投资者关系平台上答复投资者关心的问题。投资者提问：现在公司血制品院外市场占比多少？在医保控费的情况下，公司开发院外市场和下沉市场的计划怎样？华兰生物回复：您好，感谢您的关注，公司产品在院内和院外均有销售，公司将院外市场及下沉市场作为核心战略拓展方向，一方面持续夯实院内业务根基，另一方面积极完善渠道布局、加大产品推广力度，做好血液制品的销售。谢谢！以上内容为证券之星据公开信息整理，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500026324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002007","BK0197","BK0185","BK0077","BK0028","BK0188","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636847998","title":"华兰生物：现金分红是公司回馈股东的重要方式","url":"https://stock-news.laohu8.com/highlight/detail?id=2636847998","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636847998?lang=zh_cn&edition=full","pubTime":"2026-05-20 20:52","pubTimestamp":1779281536,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物05月19日在投资者关系平台上答复投资者关心的问题。股民购买公司的股票是冲着这点分红来的吗？股价受市场环境、经营业绩及行业发展前景等多重因素综合影响。现金分红是公司回馈股东的重要方式，亦是落实监管导向、保障股东合理回报的重要举措。关于回购股份，需对公司经营情况、资金安排等综合考量，如有相关计划将及时履行信息披露义务，感谢您的关注！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000041266.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0077","BK0197","BK0046","BK0188","BK0185","002007","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636847689","title":"华兰生物：华兰疫苗为公司自主设立，并非并购所得","url":"https://stock-news.laohu8.com/highlight/detail?id=2636847689","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636847689?lang=zh_cn&edition=full","pubTime":"2026-05-20 20:52","pubTimestamp":1779281536,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)05月19日在投资者关系平台上答复投资者关心的问题。投资者提问：公司在疫苗这块儿实在不怎么样，唯一的一次并购就是疫苗，还没成功，说好的新冠疫苗直到疫情结束都没能做出来，现在还拖累公司业绩，不如卖了专注血液制品创新华兰生物回复：您好，华兰疫苗为公司自主设立，并非并购所得。从合并报表口径而言，疫苗业务常年稳定贡献利润，并未长期拖累公司整体业绩。公司将同步做强血液制品主业并优化疫苗业务和重组蛋白药物业务。感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000041262.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002007","BK0188","BK0239","BK0077","BK0046","BK0197","BK0028","301207","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636861966","title":"股市必读：华兰生物（002007）5月19日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2636861966","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636861966?lang=zh_cn&edition=full","pubTime":"2026-05-20 03:49","pubTimestamp":1779220149,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘，华兰生物报收于14.07元，上涨0.43%，换手率0.41%，成交量6.49万手，成交额9104.84万元。董秘最新回复投资者： 华兰生物股票二级市场持续低迷，公司董事长二年前增持华兰生物价格15元左右，今天盘中跌破14元了，公司是否有增持计划提振信心？股价受宏观环境、政策及行业发展前景等多重因素综合影响。当日关注点来自交易信息汇总：5月19日主力资金净流出143.22万元，占总成交额1.57%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000004912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","002007","BK0188","BK0077","BK0197","BK0046","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636231710","title":"华兰生物：公司将依规按时披露季报半年报年报","url":"https://stock-news.laohu8.com/highlight/detail?id=2636231710","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636231710?lang=zh_cn&edition=full","pubTime":"2026-05-18 16:15","pubTimestamp":1779092117,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)05月18日在投资者关系平台上答复投资者关心的问题。投资者提问：以后能不能主动的预先披露下季报年报半年报？华兰生物回复：您好。根据监管规定，季报、半年报、年报均有法定披露时限，公司将依规按时披露，并在达到业绩预告标准时及时发布公告。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800022050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0077","BK0197","BK0046","BK0188","BK0185","002007","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635202518","title":"华兰生物：公司流感mRNA疫苗正按照研发计划稳步推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2635202518","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635202518?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:00","pubTimestamp":1778662833,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)05月13日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问公司mRNA疫苗产品有哪些已在临床应用，流感mRNA疫苗研发进展如何？华兰生物回复：您好，公司流感mRNA疫苗正按照研发计划稳步推进，目前处于临床前研究阶段，感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300030366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","002007","BK0028","BK0188","BK0185","159646","BK0197","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634236219","title":"股市必读：华兰生物（002007）5月11日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2634236219","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634236219?lang=zh_cn&edition=full","pubTime":"2026-05-12 01:04","pubTimestamp":1778519056,"startTime":"0","endTime":"0","summary":"截至2026年5月11日收盘，华兰生物报收于14.95元，上涨2.82%，换手率1.97%，成交量31.01万手，成交额4.59亿元。董秘最新回复投资者： 有没有考虑过剥离疫苗产业，专注血液制品创新？交易信息汇总资金流向5月11日主力资金净流入583.86万元；游资资金净流入930.37万元；散户资金净流出1514.22万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051200001196.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002007","BK0188","BK0239","BK0077","BK0046","BK0197","BK0028","BK0185"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1785558880591,"stockEarnings":[{"period":"1week","weight":0.0541},{"period":"1month","weight":0.0667},{"period":"3month","weight":-0.0319},{"period":"6month","weight":-0.1069},{"period":"1year","weight":-0.1321},{"period":"ytd","weight":-0.0773}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":-0.0681},{"period":"3month","weight":-0.0681},{"period":"6month","weight":-0.0694},{"period":"1year","weight":0.0725},{"period":"ytd","weight":-0.0344}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华兰生物工程股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"146000人(较上一季度减少0.68%)","perCapita":"10777股","listingDate":"2004-06-25","address":"河南省新乡市红旗区华兰大道甲1号","registeredCapital":"182569万元","survey":"　　华兰生物工程股份有限公司的主营业务是血液制品、疫苗、基因工程产品的研发、生产和销售。公司的主要产品是人血白蛋白、静注丙球、其他血液制品、流感疫苗。","listedPrice":15.74},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华兰生物(002007)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华兰生物(002007)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华兰生物,002007,华兰生物股票,华兰生物股票老虎,华兰生物股票老虎国际,华兰生物行情,华兰生物股票行情,华兰生物股价,华兰生物股市,华兰生物股票价格,华兰生物股票交易,华兰生物股票购买,华兰生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华兰生物(002007)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华兰生物(002007)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}